Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107,228,372
-
Total 13F shares
-
47,006,757
-
Share change
-
+6,491,576
-
Total reported value
-
$705,059,854
-
Put/Call ratio
-
667%
-
Price per share
-
$15.00
-
Number of holders
-
93
-
Value change
-
+$95,676,125
-
Number of buys
-
69
-
Number of sells
-
17
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q2 2019
As of 30 Jun 2019,
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,006,757 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Cormorant Asset Management, LP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BOXER CAPITAL, LLC, BRIDGER MANAGEMENT, LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
93
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.